Executive function in methamphetamine users with and without psychosis

ElsevierVolume 317, November 2022, 114820Psychiatry ResearchHighlights•

Methamphetamine-induced psychosis is associated with particular executive function subdomain impairments.

Psychosis symptom severity was not associated with scores on the EF composite domains.

Abstract

Methamphetamine abuse is associated with cognitive deficits across a wide range of domains. It is unclear, however, whether methamphetamine-dependent individuals with co-occurring psychosis are more impaired than those without psychosis on tests assessing executive function. We therefore aimed to compare the executive function performance of three groups: methamphetamine-dependent individuals with methamphetamine-induced psychosis (MA+; n = 20), methamphetamine-dependent individuals without psychosis (MA-; n = 19), and healthy controls (HC; n = 20). All participants were administered a neuropsychological test battery that assessed executive functioning across six sub domains (problem solving, working memory, verbal generativity, inhibition, set switching, and decision making). Analyses of covariance (controlling for between-group differences in IQ) detected significant between-group differences on tests assessing verbal generativity and inhibition, with MA+ participants performing significantly more poorly than HC. The finding that methamphetamine-induced psychosis is associated with performance impairments in particular subdomains of executive function may have implications for treatment adherence and relapse prevention.

Keywords

Cognition

Substance addiction

Substance dependence

Cognitive function

View full text

© 2022 Elsevier B.V. All rights reserved.

留言 (0)

沒有登入
gif